The Goldman Sachs Group Issues Pessimistic Forecast for Definitive Healthcare (NASDAQ:DH) Stock Price
Definitive Healthcare (NASDAQ:DH – Get Free Report) had its target price cut by The Goldman Sachs Group from $4.50 to $3.00 in a research report issued on Tuesday,Benzinga reports. The brokerage presently has a “neutral” rating on the stock. The Goldman Sachs Group’s price objective would indicate a potential upside of 8.30% from the stock’s […]
Definitive Healthcare (NASDAQ:DH – Get Free Report) had its target price cut by The Goldman Sachs Group from $4.50 to $3.00 in a research report issued on Tuesday,Benzinga reports. The brokerage presently has a “neutral” rating on the stock. The Goldman Sachs Group’s price objective would indicate a potential upside of 8.30% from the stock’s […]
